Vaccinating the majority of India’s 1.4 billion population in the next few months is going to require more than 2 billion doses. That mind-boggling number has lured a pack of pharma tycoons to jump into the fray to supply them.
For India’s Pharma Tycoons, Covid-19 Vaccines Are The New Cash Cows
